Effects of denosumab or romosozumab on vascular calcification in dialysis patients: a systematic review and meta-analysis.
INTRODUCTION Patients on hemodialysis are at high risk of vascular calcification, which contributes to cardiovascular events and mortality. The impact of osteoporosis therapies, including denosumab and romosozumab, on vascular calcification in this population remains uncertain. This systematic review and meta-analysis...